11 Biopharma CEOs To Follow On Twitter

Comments
Loading...

Twitter Inc TWTR can be an extremely useful and tradable tool for investors, but only if you follow the right people.

Here’s a look at 11 biotech and pharmaceutical company CEOs that have the potential for market-moving tweets.

1. Brent Saunders - @brentlsaunders

Saunders is the head of Allergen plc Ordinary Shares AGN, a $100 billion drug company that makes eye care, skin care and aesthetic products such as Botox.

2. Richard Pops - @popsalks

The CEO of Alkermes Plc ALKS is an active tweeter, and his company has a portfolio of about 20 drug candidates for treatment of central nervous system disorders.

3. Daphne Zohar - @daphnezohar

The CEO of Puretech Health frequently tweets about “medicine, startups, financing & other things that seem interesting.”

4. Jeff Stein - @jefflstein

Stein is the CEO of Cidara Therapeutics Inc CDTX and actively tweets about biotech news. Cidara is developing anti-infectives with a focus on serious fungal infections.

5. Hans Bishop - @HansBishop1

Bishop is the CEO of Juno Therapeutics Inc JUNO, one of many biotech companies working on novel treatments for cancer.

Related Link: 10 CEOs You Need To Follow On Twitter

6. Tim Mayleben - @TimMayleben

Mayleben is the CEO of Esperion Therapeutics Inc ESPR, a biotech company working on treatments for patients with elevated low-density lipoprotein cholesterol (LDL-C).

7. Katrine Bosley - @ksbosley

Bosley is the CEO of Editas Medicine Inc EDIT, a genome editing company focused on correcting disease-causing genes.

8. Brian Culley - @CEO_Culley

Culley is the CEO of Mast Therapeutics Inc MSTX, a biopharmaceutical company focused on treating life-threatening conditions such as sickle cell disease and heart failure.

9. Christian Homsy - @ChristianHomsy

The CEO of Celyad SA (ADR) CYAD has just 31 tweets since 2012, but they are all biotech news items relevant for traders.

10. Paul Tunnah - @pharmaphorum

Tunnah’s company pharmaphorum isn’t actually performing biotech R&D. Instead, it’s a digital pharmaceutical communication platform with exclusive news stories written by healthcare writers.

11. Stephane Bancel - @sbancel

Bancel is the CEO of Modena Therapeutics, a private company that focuses on messenger RNA applications. Bancel often tweets about biotech news and financial markets.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!